Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Stephanie Kovalchik(Cancer Genetics (United States)), Hormuzd A. Katki(Cancer Genetics (United States)), Anil K. Chaturvedi(Johns Hopkins University), Mary Korch(National Institutes of Health), Neil E. Caporaso(Department of Health and Human Services), Gerard A. Silvestri(Dartmouth College), Tom Riley(National Institutes of Health), Martin C. Tammemägi(National Institutes of Health), Christine D. Berg(National Institutes of Health)
Cited by 573
Related Papers
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
|Journal of Clinical Oncology|2008|1.6k
Methods for Staging Non-small Cell Lung Cancer
|CHEST Journal|2013|1.5k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k
Invasive Mediastinal Staging of Lung Cancer
|CHEST Journal|2007|688